Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing

February 27, 2024

Pivotal Bio Venture Partners closes $389 million fund, totaling $689 million in commitments

December 22, 2023

CD70-targeted therapies could restrict drug resistance in lung cancer

February 20, 2023

Must Read

The Future of Global Drug Regulation

August 24, 2026

Why Pharmaceutical Companies Need AI Factories

August 24, 2026

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

August 21, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Definium Bags Major Phase 3 Victory With LSD Formula

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

The Future of Global Drug Regulation

Why Pharmaceutical Companies Need AI Factories

Quantum Computing and Drug Discovery

Why Data Is Becoming Pharma’s Most Valuable Asset

Tag: Gene

AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases

Editor Picks

Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing

Pivotal Bio Venture Partners closes $389 million fund, totaling $689 million in commitments

CD70-targeted therapies could restrict drug resistance in lung cancer

Must Read

The Future of Global Drug Regulation

Why Pharmaceutical Companies Need AI Factories

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

Hot Topics

About Us

Follow Us